CAPITAL TAX AND MIGRATION

The Capital Tax which was accepted in November 11, 1942 by the 4305 Numbered Law is an extraordinary wealth tax enforced for a short-term as sixteen months taken its place as a disgrace for our history considering its consequences. It was mentioned that the capital law which was enforced by the government for taxing high-profitability due to extraordinary conditions of war was not aimed at any ethnic or religious groups. However, according to the information leaked from the Group Meeting of CHP held closed to press by Prime Minister Sukru Saracoglu, the grounds explained by the Prima Minister were different than the ones explained to press. Saracoglu said; "This is also a revolutionary law. We are against an opportunity which will provide us economic independence." And he showed his hand by saying; "We are going to eliminate the foreigners dominating our market and we shall give Turkish market under the control of Turkish people." In this study, we discuss the grounds for Capital Tax claimed to be put into force for eliminating the effects of war economy on young Turkey which has been extremely influenced even if it was not a part of the World War II, whom it is applied, how much tax has been collected and what kind of changes have happened on the demographic structure due to this tax

Volume XLVII, Number 27, January 10, 1930

Amaç: Yaygın Gelişimsel Bozukluklar (YGB) ve eşlik eden Dikkat Eksikliği Hiperaktivite Bozukluğu (DEHB) belirtileri olan olgularda Metilfenidat (MPH) ilk tedavi seçeneği olmakla birlikte, sadece DEHB olan olgulara göre daha fazla yan etkiye yol açabildiği ve klinik yanıtın çok değişken olabileceği bilinmektedir. Bu çalışmanın amacı YGB ve Hafif Düzey Mental Retardasyonu (MR) olan olguların MPH'a yanıtı- nın yalnızca DEHB olan olgularla karşılaştırılması ve CES-1 gen polimorfizmleriyle ilişkisinin bulunup bulunmadığının belirlenmesidir. Yöntem: YGB ve eşlik eden DEHB varlığında tükürük örneği alınarak MPH'ı metabolize eden enzim olan Karboksilesteraz-1 (CES-1) polimorfizmleri (Arg199/His, Ser75/Asn ve Ile49/Val) incelenmiş olup MPH yanıtı Dikkat Eksikliği ve Yıkıcı Davranış Bozuklukları için DSM-IV'e Dayalı Tarama ve Değerlendirme Ölçeği ve Klinik Global İzlem Ölçeği ile değerlendirilmiştir. Bulgular: YGB ve eşlik eden DEHB varlığında olguların, DEHB, DEHB ve eşlik eden Hafif Düzey Zeka Geriliği olan olgulara göre daha kötü MPH yanıtı verdikleri ve CES-1'de Arg199/His polimorfizminin istatistiksel olarak anlamlı oranda yüksek olduğu bulunmuştur. Sonuç: Bu çalışma YGB ve eşlik eden DEHB olan olgularda CES-1 Arg199/His polimorfizminin incelendiği ilk çalışmadır.Objective: Methylphenidate is the first-choice medication for the Pervasive Developmental Disorders (PDDs), and comorbid Attention Deficit Hyperactivity Disorder (ADHD). But this approach generally results with poor outcomes, and increased adverse effects. It is aimed to investigate the comparison of cases who diagnosed with PDDs and Mild Mental Retardation (MR) and cases with pure ADHD in terms of the clinical response to MPH. Also we aimed to investigate the relations between CES-1 polymorphism gene and the clinical response to MPH.Methods: For clarifying this we searched for three polymorphisms (Arg199/His, Ser75/Asn, and Ile49/Val) in carboxylesterase-1 gene (CES-1) in the saliva of patients diagnosed with PDD+ADHD. Also, we assessed the clinical response to MPH by dimensional approach using the Attention Deficit Hyperactivity Disorder Rating Scale IV and Clinical Global Impression-Improvement scale. Results: PDD+ADHD groups had significantly higher Arg199/His polymorphism, and clinically responded poorer with symptoms sometimes even worsening to the MPH treatment compared with "pure" ADHD and ADHD+MR groups. Conclusion: This is the first study that an association between Arg199/His polymorphism in CES1 and altered treatment response to MPH in patients with PDD that presents with symptoms of ADHD

Laboratory performance of x-ray detector on 2U cubesat beeaglesat

A CdZnTe based semiconductor X-ray detector (XRD) and its associated readout electronics has been developed by the Space Systems Design and Testing Laboratory of Istanbul Technical University and the High Energy Astrophysics Detector Laboratory of Sabanci University along with an SME partner. The XRD will be the secondary science mission on board BeEagleSat, which is developed as one of the double CubeSats for the QB50 project. QB50 is a European Framework 7 project carried out by a number of international organizations led by the von Karman Institute of Belgium. The heart of the XRD is a 2.5 mm thick, 15 mm x 15 mm CdZnTe crystal with orthogonal electrode strips on top and bottom for position resolution on the crystal. There are 3 sets of steering electrodes in between anodes. A commercial off the shelf (COTS) high voltage source provides necessary potential difference to transport electrons and holes towards electrodes. The signals from each strip are read by a COTS ASIC, RENA-3b, controlled my MSP 430. The XRD board (single ~10 cm x 10 cm board) also carries the necessary power regulators and 7 COTS batteries. In a previous paper presented at the IAC 2014, we discussed the main design of the XRD and provided results from some of the early vibration tests of the mechanical design. At the time, the CdZnTe crystal has not been attached, and the readout electronics and software were still in development phase. In this paper, we present the laboratory performance of the electronic readout system and discuss the current phase of the XRD development

Development and in orbit testing of an x ray detector within a 2U cubesat

A CdZnTe based semiconductor X-ray detector (XRD) and its associated readout electronics is developed by the Space Systems Design Laboratory of Istanbul Technical University and High Energy Astrophysics Detector Laboratory of Sabanci University along with an SME partner. The detector will utilize 30 orthogonal cross strip electrodes (and 3 steering electrodes in between anodes) whose geometry is optimized by an extensive set of simulations and energy resolution measurements. The signals will be read by RENA 3b ASIC controlled by MSP 430 microcontroller. The system will have its own battery and will be turned on intermittently due to power constraints. CdZnTe based X-ray detectors have been utilized in space, but they are either pixellated (NuStar), or they consist of many individual crystal pieces (BAT in Swift satellite). The aim of the XRD is to show that large volume crystals with orthogonal strips are viable alternatives, especially for small satellite systems with medium energy resolution requirement. XRD will also characterize the hard X-ray background in 20-200 keV at low Earth orbit conditions as a function of altitude. Due to power and telemetry constraints, the individual events will be corrected for hole trapping on-board, histogrammed, and only the X-ray spectra will be transmitted to the ground station along with a small set of raw data for diagnostic purposes. The XRD is planned to travel into space, as a secondary science mission, on board BeEaglesat which is a 2U CubeSat developed as one of the possible double (2U) CubeSats for the QB50 project. QB50 is a European Framework 7 (FP7) project carried out by a number of international organizations led by the von Karman Institute of Belgium. Its main scientific objective is to study in situ the temporal and spatial variations of a number of key constituents and parameters in the lower thermosphere with a network of about 50 double and triple CubeSats, separated by few hundred kilometers and carrying a determined set of sensors

The epidemiology, Clinical Manifestations, radiology, microbiology, treatment, and prognosis of echinococcosis: Results of NENEHATUN study

Aim: Echinococcosis, caused by Echinococcus species, is an important zoonotic disease causing major health problems in humans and animals. Herein, we aimed to evaluate the epidemiology, clinical and laboratory parameters, radiological, serological, pathological, and treatment protocols of followed-up cases of hydatidosis. Methods: A total of 550 patients diagnosed with hydatid cyst disease were included in this study. Patients who were positive for one or more of the enzyme-linked immunosorbent assay or indirect hemagglutination test, pathological results, or radiological findings were examined. The data analyzed were collected from nine centers between 2008 and 2020. Records were examined retrospectively. Results: Among the patients, 292 (53.1%) were women and 258 (46.9%) were men. The patients' mean age was 44.4 +/- 17.4 years. A history of living in rural areas was recorded in 57.4% of the patients. A total of 435 (79.1%) patients were symptomatic. The most common symptoms were abdominal pain in 277 (50.4%), listlessness in 244 (44.4%), and cough in 140 (25.5%) patients. Hepatomegaly was found in 147 (26.7%), and decreased breath sounds were observed in 124 (22.5%) patients. Radiological examination was performed in all cases and serological methods were also applied to 428 (77.8%) patients. The most frequently applied serological test was IHA (37.8%). A single cyst has been found in 66% patients. Hepatic involvement occurred in 327 (59.4%), pulmonary involvement was found in 128 (23.3%), whereas both of them were recorded in 43 (7.8%) patients. Splenic involvement was only detected in nine (1.6%) patients. Echinococcus granulosus (72.5%) was most frequently detected. Cyst diameters of 56.9% of the patients were in the range of 5-10 cm. A total of 414 (75.2%) patients received albendazole as an antiparasitic. Mortality was noted in nine (1.6%) patients. Conclusion: Echinococcosis is an important public health problem in Turkey. It can affect the social, economic, and political structures of the community. Public education and awareness are extremely important

Yeni medyanın toplumsal yansımaları

Yeni medya, hayatımızın her alanında etkisini gösteren ve değiştiren bir olgu haline gelmiştir. Günümüzde insanlar, haberlerini, bilgilerini ve iletişimlerini yeni medya araçları aracılığıyla alıp vermektedirler. Bu araçlar, çok çeşitli işlevleri yerine getirerek kullanıcılarına hız, çeşitlilik, çok seslilik, derinlik, yeni katmanlar, kolaylıklar ve çeşitli seviyelerde iletişim imkanları sunmaktadır. Ancak bu avantajların yanı sıra, yeni medya araçları beraberinde çeşitli sorunları da getirmektedir. Özellikle sosyal medya platformları, kişisel bilgilerin paylaşımı, zorbalık, nefret söylemi ve özel hayatın ihlali gibi güvenlik sorunlarını da beraberinde getirmektedir. Bunun yanı sıra, sosyal medya üzerinden yayılan yanlış bilgiler, manipülasyon ve sahte haberler, hakikatin Önemsizleşmesi gibi sorunları da ortaya çıkarmaktadır..

Epidemiology of pemphigus in Turkey: One-year prospective study of 220 cases

Pemphigus is a group of rare and life-threatening autoimmune blistering diseases of the skin and mucous membranes. Although they occur worldwide, their incidence shows wide geographical variation, and prospective data on the epidemiology of pemphigus are very limited. Objective of this work is to evaluate the incidence and epidemiological and clinical features of patients with pemphigus in Turkey. All patients newly diagnosed with pemphigus between June 2013 and June 2014 were prospectively enrolled in 33 dermatology departments in 20 different provinces from all seven regions of Turkey. Disease parameters including demography and clinical findings were recorded. A total of 220 patients were diagnosed with pemphigus during the 1-year period, with an annual incidence of 4.7 per million people in Turkey. Patients were predominantly women, with a male to female ratio of 1:1.41. The mean age at onset was 48.9 years. Pemphigus vulgaris (PV) was the commonest clinical subtype (n=192; 87.3%), followed by pemphigus foliaceus (n=21; 9.6%). The most common clinical subtype of PV was the mucocutaneous type (n=83; 43.2%). The mean Pemphigus Disease Area Index was 28.14±22.21 (mean ± Standard Deviation).  The incidence rate of pemphigus in Turkey is similar to the countries of South-East Europe, higher than those reported for the Central and Northern European countries and lower than the countries around the Mediterranean Sea and Iran. Pemphigus is more frequent in middle-aged people and is more common in women. The most frequent subtype was PV, with a 9-fold higher incidence than pemphigus foliaceus.   </p

Post COVID-19 irritable bowel syndrome

Objectives: The long-term consequences of COVID-19 infection on the gastrointestinal tract remain unclear. Here, we aimed to evaluate the prevalence of gastrointestinal symptoms and post-COVID-19 disorders of gut-brain interaction after hospitalisation for SARS-CoV-2 infection. Design: GI-COVID-19 is a prospective, multicentre, controlled study. Patients with and without COVID-19 diagnosis were evaluated on hospital admission and after 1, 6 and 12 months post hospitalisation. Gastrointestinal symptoms, anxiety and depression were assessed using validated questionnaires. Results: The study included 2183 hospitalised patients. The primary analysis included a total of 883 patients (614 patients with COVID-19 and 269 controls) due to the exclusion of patients with pre-existing gastrointestinal symptoms and/or surgery. At enrolment, gastrointestinal symptoms were more frequent among patients with COVID-19 than in the control group (59.3% vs 39.7%, p&lt;0.001). At the 12-month follow-up, constipation and hard stools were significantly more prevalent in controls than in patients with COVID-19 (16% vs 9.6%, p=0.019 and 17.7% vs 10.9%, p=0.011, respectively). Compared with controls, patients with COVID-19 reported higher rates of irritable bowel syndrome (IBS) according to Rome IV criteria: 0.5% versus 3.2%, p=0.045. Factors significantly associated with IBS diagnosis included history of allergies, chronic intake of proton pump inhibitors and presence of dyspnoea. At the 6-month follow-up, the rate of patients with COVID-19 fulfilling the criteria for depression was higher than among controls. Conclusion: Compared with controls, hospitalised patients with COVID-19 had fewer problems of constipation and hard stools at 12 months after acute infection. Patients with COVID-19 had significantly higher rates of IBS than controls. Trial registration number: NCT04691895